The benefits of HBOT.
The full outcome map. Each benefit with the mechanism that drives it, the evidence behind it, and the R1SE protocol that targets it. Sorted by how quickly you'll notice them.
01
Deeper, more restorative sleep
The single most universal benefit members report — usually noticeable within the first 1–3 sessions.
Almost every R1SE member who runs more than three HBOT sessions reports better sleep within the first week. Deeper, longer, and a more rested wake-up. The objective sleep-quality literature (PSQI scores, sleep efficiency on consumer wearables) tends to track the subjective report.
Mechanism: HBOT shifts autonomic balance toward parasympathetic dominance for several hours post-session. Combined with the improved cerebral perfusion and the gentle catecholamine drop on chamber exit, the body lands in the right state for sleep onset and consolidation.
Mechanism
Improved cerebral perfusion and autonomic regulation, plus the post-session parasympathetic afterglow as oxygen-rich plasma redistributes.
Evidence
Subjective sleep quality and PSQI improvement reported consistently across HBOT trials in healthy and clinical populations.
R1SE protocol
Beginner intro 1.3–1.5 ATA; any working protocol delivers this benefit.
02
Sharper attention & cognitive performance
Hadanny 2020 demonstrated this in healthy older adults; R1SE members in their 30s, 40s and 50s report the same direction of effect.
The Hadanny cognitive findings were in healthy older adults — participants without diagnosed deficits. Attention, processing speed, executive function and global cognition all improved at statistically meaningful magnitudes. This positions HBOT as a cognitive enhancement tool, not just a recovery one.
Members in younger age brackets report the most-noticeable changes in attention (longer focus, less mid-afternoon fatigue) and processing speed (decisions, work output). The effect compounds across a 20-session block.
Mechanism
Increased cerebral blood flow (post-HBOT MRI evidence), BDNF elevation, mitochondrial biogenesis via the hyperoxic-hypoxic paradox.
Evidence
Hadanny et al. (Aging 2020) — 8 of 9 cognitive domains improved in healthy adults aged 64+ after 60 sessions.
R1SE protocol
Cognitive performance block: 1.75–2.0 ATA, 60–90 min, 3× weekly for 20–40 sessions.
03
Faster recovery from training & illness
Accelerated repair across muscle, soft tissue and post-illness fatigue — without the inflammation-blunting risk that cold immersion carries.
The reason elite athletes (Phelps, LeBron, Ronaldo) invest heavily in HBOT is the recovery signal. Soft-tissue injury healing accelerates. Post-training inflammation resolves faster. Subjective “heaviness” in the legs after a hard block clears within hours instead of days.
Schedule HBOT 4+ hours after heavy strength training if hypertrophy is your goal — the anti-inflammatory effect can blunt mTOR signalling. After cardio or competition, time it however suits.
Mechanism
Oxygen delivery to hypoxic tissue, fibroblast proliferation, accelerated angiogenesis in damaged tissue, stem cell mobilisation.
Evidence
Thom et al. (2006) — 8× CD34+ stem cell mobilisation after 20 sessions. Branco / Ferraresi reviews of athletic populations.
R1SE protocol
Recovery: 1.5–1.75 ATA, 60 min, 1–2× per week.
04
Skin elasticity, tone & repair
Dermal fibroblast activation drives collagen synthesis, microcirculation, and faster wound and laser-treatment recovery.
HBOT is not marketed as a primary skin treatment in the way red light therapy is — but the underlying mechanism (fibroblast proliferation, collagen synthesis, microcirculation) is the same. Members on longer HBOT protocols frequently report improved skin tone, faster recovery from dermatological procedures, and visible reduction in fine lines over months.
The most powerful combination is HBOT plus red light. Both target the same cellular machinery; red light delivers photons to drive ATP production, HBOT delivers oxygen pressure to drive everything downstream.
Mechanism
HBOT activates fibroblasts (the same cells red light therapy targets), boosts Type I/III collagen synthesis, and increases skin microcirculation.
Evidence
Wound healing meta-analyses (Kranke Cochrane 2015) confirm fibroblast-driven repair. R1SE members report visible improvements in skin tone and recovery from sun damage.
R1SE protocol
Stack HBOT 1.5–1.75 ATA with Red Light Therapy 660+850nm 2× weekly.
05
Lower systemic inflammation
HBOT modulates the inflammatory cytokines that drive chronic disease and post-exercise pain.
Chronic low-grade inflammation underlies most of the modern lifestyle diseases — cardiovascular, metabolic, neurodegenerative. HBOT's anti-inflammatory signal is one of the more clinically meaningful aspects of the modality. Members frequently report reductions in joint pain, post-exercise soreness, and the general “everything-hurts” feeling that creeps in after 40.
The flip side: don't use HBOT to chronically suppress inflammation that's telling you something important (active injury, autoimmune flare, infection). The team will discuss timing if you're managing an inflammatory condition.
Mechanism
Direct suppression of TNF-α, IL-6, and IL-1β production; activation of the Nrf2 antioxidant pathway; reduced ROS damage downstream.
Evidence
Multiple mechanistic studies show acute and chronic anti-inflammatory effects; long-COVID and fibromyalgia trials confirm clinical translation.
R1SE protocol
Recovery / post-illness: 1.5–2.0 ATA, 60–90 min, 2–3× weekly.
06
Sustained energy & reduced fatigue
Members consistently report a step-change in baseline energy after 5–15 HBOT sessions — particularly meaningful for post-viral and long-COVID populations.
The energy effect is what most converts members to a long-term protocol. The initial sessions feel restorative; by sessions 10–15 the baseline shifts — you wake up more rested, the afternoon dip is smaller, and the post-work fatigue is less heavy.
Mechanistically, this is mitochondrial. HBOT drives biogenesis of new mitochondria via the hyperoxic-hypoxic paradox, and existing mitochondria function more efficiently in oxygen-rich plasma. More energy capacity per cell.
Mechanism
Mitochondrial biogenesis (more energy-producing organelles per cell), improved oxygen utilisation, reduced metabolic inefficiency from chronic inflammation.
Evidence
Zilberman-Itskovich (2022) long-COVID RCT showed significant energy improvement vs sham. Subjective energy reports are consistent across the HBOT literature.
R1SE protocol
Post-illness / sustained energy: 1.5–1.75 ATA, 60 min, 3× weekly for 20–40 sessions.
07
Better immune resilience
Reduced sickness frequency, faster recovery from infections, modulated inflammatory response.
The immune signal is one of the quieter HBOT benefits — you don't notice it until you stop catching every cold that goes round. Members who run consistent HBOT through winter consistently report fewer respiratory infections and shorter durations when they do catch something.
Mechanism: more circulating immune cell precursors (stem cell mobilisation), enhanced phagocytic activity in white blood cells under hyperoxic conditions, and the broader anti-inflammatory effect that lets the immune system signal cleanly rather than chronically.
Mechanism
Stem cell mobilisation (CD34+) supports immune cell production. White blood cell function improves under hyperoxic conditions. Inflammatory regulation shifts favourably.
Evidence
Kox et al. (2014) showed HBOT-trained subjects modulated their inflammatory response to bacterial endotoxin. Long-term HBOT users report lower seasonal illness frequency.
R1SE protocol
Maintenance: 1.3–1.5 ATA, 30–60 min, 1× per week sustains the signal.
08
Anti-aging cellular signals
Telomere lengthening and senescent cell clearance — the closest thing aging research currently has to a measurable reversal.
The Hachmo telomere finding is the strongest aging signal HBOT has produced — arguably the strongest aging signal any intervention has produced in a clean RCT. Telomere shortening is a hallmark of cellular aging; cellular senescence accumulates with age and drives chronic disease. HBOT moved both metrics in the favourable direction.
Important caveat: this was one trial in a specific population (healthy adults 64+) at a specific dose (2.0 ATA, 60 sessions). R1SE offers the protocol that produced the finding — with full transparency about what's known and not. We don't market HBOT as an “anti-aging treatment” in any unqualified sense.
Mechanism
Hyperoxic-hypoxic paradox drives the same signalling as caloric restriction and exercise (HIF-1α, mitochondrial biogenesis, senolytic clearance).
Evidence
Hachmo et al. (Aging 2020) — 38% T-cell telomere lengthening and 33% senescent cell reduction after 60 sessions at 2.0 ATA.
R1SE protocol
Longevity (Hachmo): 2.0 ATA, 90 min, 5× weekly for 60 sessions over ~3 months.
Common questions
Pick a benefit. Pick a protocol.
Our team will recommend the right pressure, duration, and frequency for the outcome you're most after.
Continue Reading
More from the R1SE HBOT Library
HBOT Knowledge Hub
Every hyperbaric oxygen page on the R1SE knowledge library.
ReadThe Science of HBOT
Telomere lengthening, cognitive enhancement, neuroplasticity — every claim cited.
ReadConditions HBOT Treats
Post-concussion, long COVID, ulcers, stroke, fibromyalgia.
ReadHow to Use HBOT
Pressure, duration, frequency — from beginner to protocol-grade.
ReadTypes of Hyperbaric Chamber
Hard- vs soft-shell. 1.3 vs 2.0 ATA. Monoplace vs multiplace.
ReadMild vs Medical HBOT
1.3 ATA wellness vs hospital-grade 2.0+ ATA, side by side.
Read